GENE ONLINE|News &
Opinion
Blog

2025-03-14|

Study Finds Married Men Three Times More Likely to Be Obese Than Single Men

by Mark Chiang
Share To

Research set to be presented at the European Congress on Obesity (ECO 2025) in Malaga, Spain, reveals that marriage significantly increases the likelihood of obesity among men. The study, conducted by Dr. Alicja Cicha-Mikołajczyk and her team from the National Institute of Cardiology in Warsaw, Poland, indicates that married men are three times more likely to live with obesity compared to their single counterparts. Additionally, marriage raises the risk of being overweight by 62% for men and 39% for women.

The findings highlight a gender disparity in how marital status affects weight. While marriage does not appear to elevate women’s risk of obesity, it does increase their chances of being overweight. The researchers analyzed data from a broad population sample to assess correlations between marital status and body weight metrics. Their work will be formally presented during ECO 2025, which runs from May 11–14 in Malaga.

Date: 13 March, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Oxford Study Reveals Stopping Weight Loss Medications Accelerates Rebound Faster Than Ending Behavioral Programs
2026-03-05
World Obesity Day 2026 Highlights 8 Billion Reasons to Reshape Global Health Systems
2026-03-05
AstraZeneca Pledges $15 Billion China Investment and Signs Up to $18.5 Billion CSPC Obesity Deal
2026-02-02
LATEST
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates
2026-03-17
SurgePays Launches Nationwide Campaign to Promote LinkUp Mobile Service
2026-03-17
Tempus and Blood Cancer United Collaborate to Build Extensive Pediatric AML Data Registry
2026-03-17
John Choe Appointed Western Sales Director at Buzz Bomb Caffeine Company
2026-03-17
Two RXO Leaders Earn Fourth Consecutive Recognition in Supply Chain Pros to Know Awards
2026-03-17
Pfizer Reports Phase 2 Trial Success for Atirmociclib in Second-Line Metastatic Breast Cancer Treatment
2026-03-17
Merck to Present Long-Term Efficacy Data on GARDASIL9 and GARDASIL at EUROGIN 2026
2026-03-17
Scroll to Top